Patient basic information Patient: Mr. Matthew (Matthew Ramirez) Nationality: Iceland Diagnosis: Brain tumor Diagnostic Hospital: University of Hong Kong Shenzhen Hospital Treatment: Precision medical + personalized treatment Holidays: 98 days Treatment cost: approximately 542204 yuan Treatment effect: Complete relief After arriving at the Shenzhen Hospital of the University of Hong Kong, the International Medical Services team arranged for the first time multidisciplinary MDT for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and landing services throughout the treatment process. The team of experts at the Shenzhen Hospital of the University of Hong Kong uses a comprehensive set of precise medical + individualized treatments, during the treatment the medical team closely monitors the patient's various indicators, dynamic adjustment programs.
After 98 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. The patient's treatment effects were finally completely alleviated. When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through a remote follow-up system.
The patient commented: 'The level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals impressed us, and every link from the ground to the hospital was arranged with a line. Thank you to the medical team at Shenzhen Hospital of the University of Hong Kong, and thank you to the knowledgeable care provided by the translators and accompanying staff. 'Mr.
Liu Matthew criticized the case as a typical case of cross-border suspected seriousness clinical cases. The University of Hong Kong Shenzhen Hospital relies on a multidisciplinary collaborative mechanism to develop precise medical + individualized treatments for brain tumors, reflecting the integrated strength of Chinese hospitals in the field of suspected diagnostics, and a shortened version of how international medical services are regulated.